EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Living Biohybrid Hydrogels for Co‐Delivery of Oxygen, Anti‐Cancer Drugs, and Probiotics: Effects on Cancer and Healthy Cell Viability

Ulvi Süleymanzade iD, Tugba Ezgi Şahin, Yagmur Damla Demir, Yagmur Eylül Yatar, Nermin Seda Kehr iD

Macromolecular Bioscience · 2026

DOI: 10.1002/mabi.70233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Ulvi Süleymanzade und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Izmir Institute of Technology, Urla/Izmir, Türkiye. Hauptthemen laut MEDLINE: Probiotics, Hydrogels, Doxorubicin, Oxygen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Scientific and Technological Research Council of Turkey, Türkiye Bilimsel ve Teknolojik Araştirma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent studies, oxygen (O 2 ) delivery biomaterials have been developed to reduce hypoxia‐induced problems in, e.g., tumor tissues. However, none of these studies have used inhibitory effects of probiotics in combination therapies with O 2 and anticancer drugs for advanced cancer treatment applications. In this study, we report a new probiotic‐enriched 3D‐printed biomaterial (3D‐BioHybrid‐DOX/SPEP) that is capable of O 2 , probiotic, and acidic pH (pH 6.0) sensitive anticancer drug (Doxorubicin = DOX) co‐release. 3D‐BioHybrid‐DOX/SPEP shows sustained O 2 and pH‐responsive anticancer drug release over 14 days. The release of short‐chain fatty acids, including butyric acid, was detected on days 1 and 7 of incubation, indicating that the O 2 delivery component of the system supports probiotic viability while mitigating the toxic effects of DOX. The CFU results show that the 3D‐BioHybrid‐DOX/SPEP supports probiotic viability at 1 and 7 days of incubation. In vitro cell experiments indicate that the healthy cell viability is ca. 2 times higher than cancer cells after 1 and 7 days of incubation at hypoxia conditions in 3D‐BioHybrid‐DOX/SPEP due to the co‐administration of O 2 , DOX, and probiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsHydrogelsDoxorubicinOxygenAntineoplastic AgentsNeoplasmsDrug Delivery SystemsHumansCell SurvivalHydrogen-Ion ConcentrationCell Line, Tumor

Stichwörter der Autor:innen

biohybrid hydrogelshypoxiapH‐responsive deliveryprobiotics

Substanzen

HydrogelsDoxorubicinOxygenAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, Izmir Institute of Technology, Urla/Izmir, Türkiye.

ORCID-Profile: Ulvi Süleymanzade, Nermin Seda Kehr

Förderung

  • Scientific and Technological Research Council of Turkey
  • Türkiye Bilimsel ve Teknolojik Araştirma Kurumu

Zitieren

APA

Süleymanzade, U., Şahin, T. E., Demir, Y. D., Yatar, Y. E., & Kehr, N. S. (2026). Living Biohybrid Hydrogels for Co‐Delivery of Oxygen, Anti‐Cancer Drugs, and Probiotics: Effects on Cancer and Healthy Cell Viability. Macromolecular Bioscience. https://doi.org/10.1002/mabi.70233

Vancouver

Süleymanzade U, Şahin TE, Demir YD, Yatar YE, Kehr NS. Living Biohybrid Hydrogels for Co‐Delivery of Oxygen, Anti‐Cancer Drugs, and Probiotics: Effects on Cancer and Healthy Cell Viability. Macromolecular Bioscience. 2026. doi:10.1002/mabi.70233

BibTeX
@article{Sleymanzade2026,
  author = {Süleymanzade, Ulvi and Şahin, Tugba Ezgi and Demir, Yagmur Damla and Yatar, Yagmur Eylül and Kehr, Nermin Seda},
  title = {Living Biohybrid Hydrogels for Co‐Delivery of Oxygen, Anti‐Cancer Drugs, and Probiotics: Effects on Cancer and Healthy Cell Viability},
  journal = {Macromolecular Bioscience},
  year = {2026},
  doi = {10.1002/mabi.70233}
}
Kostenlos starten →